391 G (Carbidopa and levodopa extended release 50 mg / 200 mg)

This pill with imprint "391 G" is Purple, Elliptical / Oval and has been identified as Carbidopa and levodopa extended release 50 mg / 200 mg. It is manufactured by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa extended release

Imprint:

391 G

Strength:

50 mg / 200 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Global Pharmaceuticals

National Drug Code (NDC):

00115-3911

Inactive Ingredients:

hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.